CFDE Data Portal | Search TM4SF19-AS1

	Label	Description
	TM4SF19-AS1 associations Collection (Entity type)	Associations for TM4SF19-AS1_associations
	TM4SF19-AS1 associations.tsv File (Entity type)	A file from IDG as part of the Harmonizome project
	TM4SF19-AS1 Gene (Entity type)	ENSG00000235897 - TM4SF19 antisense RNA 1
	GSE229973 3 V 2 CISPLATIN HUMAN DN Gene Set (Entity type)	A Gene Set from LINCS
	GSE125956 SYK knockdown 4 v 2 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE111247 temozolomide LN-308 0 v 6 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE172016 paclitaxel 2 v 5 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE210476 11 V 4 RUTAECARPINE HUMAN DN Gene Set (Entity type)	A Gene Set from LINCS
	GSE146358 dopamine 5 v 2 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE236228 penfluridol 0 v 1 human up Gene Set (Entity type)	A Gene Set from LINCS

TM4SF19-AS1 associations

Associations for TM4SF19-AS1_associations

TM4SF19-AS1 associations.tsv

A file from IDG as part of the Harmonizome project

TM4SF19-AS1

ENSG00000235897 - TM4SF19 antisense RNA 1

GSE229973 3 V 2 CISPLATIN HUMAN DN

A Gene Set from LINCS

GSE125956 SYK knockdown 4 v 2 human up

A Gene Set from LINCS

GSE111247 temozolomide LN-308 0 v 6 human up

A Gene Set from LINCS

GSE172016 paclitaxel 2 v 5 human dn

A Gene Set from LINCS

GSE210476 11 V 4 RUTAECARPINE HUMAN DN

A Gene Set from LINCS

GSE146358 dopamine 5 v 2 human up

A Gene Set from LINCS

GSE236228 penfluridol 0 v 1 human up

A Gene Set from LINCS

DISPLAY PER PAGE

@CFDE Workbench 2026

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2026

This repository is under review for potential modification in compliance with Administration directives.